InDex Pharmaceuticals Holding AB (publ) Stock Nasdaq Stockholm
Equities
SE0008966295
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 190M 2.07B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.82B | Net income 2025 * | -221M -2.4B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 938M | Net Debt 2025 * | 306M 3.32B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.73
x | P/E ratio 2025 * |
-0.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 |
1st Jan change | Capi. | |
---|---|---|
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |